DE69018903D1 - Verwendung von Prostansäurederivaten zur Herstellung von Arzneimitteln zur Verbesserung der Ausscheidung von Nichtprotein in die Därme. - Google Patents

Verwendung von Prostansäurederivaten zur Herstellung von Arzneimitteln zur Verbesserung der Ausscheidung von Nichtprotein in die Därme.

Info

Publication number
DE69018903D1
DE69018903D1 DE69018903T DE69018903T DE69018903D1 DE 69018903 D1 DE69018903 D1 DE 69018903D1 DE 69018903 T DE69018903 T DE 69018903T DE 69018903 T DE69018903 T DE 69018903T DE 69018903 D1 DE69018903 D1 DE 69018903D1
Authority
DE
Germany
Prior art keywords
excretion
intestines
medicaments
protein
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69018903T
Other languages
English (en)
Other versions
DE69018903T2 (de
Inventor
Ueno Ryuji
Osama Hiroyoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Application granted granted Critical
Publication of DE69018903D1 publication Critical patent/DE69018903D1/de
Publication of DE69018903T2 publication Critical patent/DE69018903T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicinal Preparation (AREA)
DE69018903T 1989-08-09 1990-07-31 Verwendung von Prostansäurederivaten zur Herstellung von Arzneimitteln zur Verbesserung der Ausscheidung von Nichtprotein in die Därme. Expired - Lifetime DE69018903T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20589589 1989-08-09

Publications (2)

Publication Number Publication Date
DE69018903D1 true DE69018903D1 (de) 1995-06-01
DE69018903T2 DE69018903T2 (de) 1995-08-24

Family

ID=16514522

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69018903T Expired - Lifetime DE69018903T2 (de) 1989-08-09 1990-07-31 Verwendung von Prostansäurederivaten zur Herstellung von Arzneimitteln zur Verbesserung der Ausscheidung von Nichtprotein in die Därme.

Country Status (5)

Country Link
US (1) US5126372A (de)
EP (1) EP0415564B1 (de)
AT (1) ATE121624T1 (de)
CA (1) CA2022372C (de)
DE (1) DE69018903T2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080255499A1 (en) * 2005-11-18 2008-10-16 Renobiz Co ., Ltd Compositions for Peritoneal Dialysis
CN101410097A (zh) 2006-01-24 2009-04-15 株式会社·R-技术上野 软明胶胶囊制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153858A3 (de) * 1984-02-29 1985-12-11 The Upjohn Company Therapeutische Anwendung von Protaglandinen
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
EP0292177B1 (de) * 1987-05-15 1992-03-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Fiebersteigende Zusammensetzung
GB2209939B (en) * 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
ATE78465T1 (de) * 1987-10-02 1992-08-15 Ueno Seiyaku Oyo Kenkyujo Kk Kathartica.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 13,14−ジヒドロ−15−ケトプロスタグランジン類の安定化
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
EP0343904B1 (de) * 1988-05-23 1993-04-28 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Hypersphyxia verursachende Zusammensetzung

Also Published As

Publication number Publication date
EP0415564A2 (de) 1991-03-06
EP0415564A3 (en) 1992-07-08
DE69018903T2 (de) 1995-08-24
EP0415564B1 (de) 1995-04-26
CA2022372A1 (en) 1991-02-10
ATE121624T1 (de) 1995-05-15
US5126372A (en) 1992-06-30
CA2022372C (en) 2000-05-02

Similar Documents

Publication Publication Date Title
ATA290483A (de) Verwendung von neuen 2-pyridylalkyl-sulfinylbenzimidazolen zur herstellung von die magensaeuresekretion beeinflussenden pharmazeutischen praeparaten
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
DE59005250D1 (de) Neue Thienylcarbonsäureester von Aminoalkoholen, ihre Quaternierungsprodukte sowie die Herstellung und Verwendung dieser Verbindungen.
ES555147A0 (es) Un procedimiento para la produccion de un compuesto de tiazolidindiona hipoglicemico
FI102836B1 (fi) Menetelmä glykosaminoglykaanilla muunnetun proteiinin valmistamiseksi
DE3261237D1 (en) Sulphur-containing 5-hydroxy-alkanoic acid derivatives, their use as pharmaceutical preparations and process for their production
DE69026306D1 (de) Verfahren für die Herstellung von Polyethylenglykolderivate und modifizierte Proteine.
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
ES545194A0 (es) Un procedimiento para preparar derivados de purina
ES2054738T3 (es) Derivados de acido 3-desmetil-4-fluoromevalonico, procedimiento para su preparacion, preparados farmaceuticos a base de estos compuestos, su empleo y productos intermedios.
CS274677B2 (en) Method of 7-piperazino-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxyl acid's derivatives production
DE69018903D1 (de) Verwendung von Prostansäurederivaten zur Herstellung von Arzneimitteln zur Verbesserung der Ausscheidung von Nichtprotein in die Därme.
ATE55250T1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
ATE125805T1 (de) Furanderivate.
DE3578374D1 (de) Verwendung von chinolonen fuer die herstellung eines arzneimittels zur behandlung von herzerkrankungen.
ATE122563T1 (de) Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
ATE112276T1 (de) Aryl-chinolyl-substituierte 1,4-dihydropyridin- dicarbonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
DE69305250D1 (de) Herstellung von Alkandicarbonsäurederivaten
DE3686534D1 (de) Verwendung eines retinoids zur herstellung eines zytostatischen arzneimittels.
ES2039386T3 (es) Procedimiento para preparar oxolabdanos y su utilizacion para preparar medicamentos.
DK9588D0 (da) 2,1-benzothiazepin-2,2-dioxid-5-carboxylsyrederivater
DE3685222D1 (de) Galleersetzende, die fettverdauung foerdernde arzneimittelpraeparate und verfahren zu ihrer herstellung.
JPS52156900A (en) Process for preparing 9*100dihydroergocine and physiologically acceptable acid additives thereof and application as medicine
DE3578065D1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate, verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SUCAMPO AG, ZUG, CH